Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,282 total articles

Global Mofy Enters into Strategic Cooperation with Infinigence AI to Jointly Build an Industrial-Grade AIGC Content Creation Platform

Global Mofy Enters into Strategic Cooperation with Infinigence AI to Jointly Build an Industrial-Grade AIGC Content Creation Platform

Global Mofy AI Limited (Nasdaq: GMM) announced a strategic cooperation agreement with Shanghai Infinigence AI Co., Ltd. to jointly develop an industrial-grade AI-generated content (AIGC) creation platform. The platform aims to integrate AI infrastructure, model capabilities, and content ecosystems to enhance efficiency, collaboration, and quality i…

TOMI Environmental Solutions, Inc. Announces Unaudited Preliminary Financial Results for Q1 2026 Revenue Reflecting Strong Sequential Revenue Growth Over Q4

TOMI Environmental Solutions, Inc. Announces Unaudited Preliminary Financial Results for Q1 2026 Revenue Reflecting Strong Sequential Revenue Growth Over Q4

TOMI Environmental Solutions, Inc. announced preliminary unaudited Q1 2026 revenue of approximately $1.7 million, marking a 67% sequential increase over Q4 2025. The company's integrated projects pipeline grew to $5.3 million with 14 customers, half secured by contracts or purchase orders, reflecting strong demand for their SteraMist Integrated Sys…

Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)

Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)

Longeveron Inc. announced the granting of a Chinese patent covering potency assay methods for evaluating human mesenchymal stem cells (MSCs) derived from various tissues. This patent strengthens Longeveron's international portfolio, protecting its cell-based therapies, including its lead investigational product laromestrocel (Lomecel-B), which is i…

Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities

Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities

Psyence Biomedical Ltd. has expanded its Australian clinical site network from three to five sites, including Ramsay Health Care and NeuroCentrix, to support its ongoing Phase IIb clinical trial of natural psilocybin (NPX-5) for treating Adjustment Disorder in cancer patients receiving palliative care. This strategic move aims to enhance patient re…

FinWise Bancorp Announces Leadership Transition Appointing Jim Noone as Chief Executive Officer of the Holding Company

FinWise Bancorp Announces Leadership Transition Appointing Jim Noone as Chief Executive Officer of the Holding Company

FinWise Bancorp has appointed Jim Noone as CEO effective April 6, 2026, following a multi-year succession plan. The former CEO, Kent Landvatter, will transition to Executive Chairman to maintain strategic continuity. The leadership change maintains the company’s strategic direction and priorities, emphasizing stability and ongoing execution of its …

Garrett Motion Showcases Breakthrough Oil-Free Centrifugal Compressor Portfolio at China Refrigeration Expo 2026

Garrett Motion Showcases Breakthrough Oil-Free Centrifugal Compressor Portfolio at China Refrigeration Expo 2026

Garrett Motion Inc. introduces a new portfolio of oil-free centrifugal compressors designed for data centers, battery energy storage systems, and industrial/commercial cooling markets. These compressors offer enhanced energy efficiency, reduced maintenance, and accommodate ultra-low-GWP refrigerants, positioning Garrett as a leader in next-generati…

Telix Strengthens Board with Additional Director Appointments

Telix Strengthens Board with Additional Director Appointments

Telix Pharmaceuticals Limited announces the appointment of two distinguished Non-Executive Directors, Maria Rivas, MD, and William Jellison, effective May 2026, to enhance the Board's expertise in US public company governance, clinical development, and financial oversight. This strategic expansion supports Telix's evolution as a dual-listed global …

SPX Technologies to Report First Quarter 2026 Financial Results

SPX Technologies to Report First Quarter 2026 Financial Results

SPX Technologies, Inc., a diversified global supplier specializing in engineered products for HVAC and detection markets, announced it will report its first quarter fiscal 2026 financial results on April 30, 2026, after U.S. markets close. The company will host a webcasted conference call to discuss the results and business outlook.

LAX Transforms the Travel Experience with Daktronics Video Display System Upgrade at Tom Bradley International Terminal

LAX Transforms the Travel Experience with Daktronics Video Display System Upgrade at Tom Bradley International Terminal

Daktronics has been chosen by Los Angeles World Airports to provide a comprehensive upgrade to digital displays at LAX's Tom Bradley International Terminal. The project features over 30 integrated LED displays covering more than 15,000 square feet, enhancing traveler experience with cutting-edge visual technology. Installation will continue through…

First Fed Bank names Jennifer Gribble as Chief People Officer

First Fed Bank names Jennifer Gribble as Chief People Officer

First Northwest Bancorp, a Nasdaq-listed financial holding company and parent of First Fed Bank, announced the appointment of Jennifer Gribble as Chief People Officer, effective March 31, 2026. Gribble, an experienced HR leader, will lead talent acquisition, engagement, and organizational transformation initiatives to support the bank's modernizati…

AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

AtaiBeckley Inc. announced positive Phase 2a clinical trial results showing that a single intranasal dose of BPL-003 achieved rapid (Day 2) and durable antidepressant responses in treatment-resistant depression patients who were also on stable SSRI therapy. The drug, which holds FDA Breakthrough Therapy Designation, was well tolerated with fast pat…

Eagle Bancorp Announces Earnings Call on April 23, 2026

Eagle Bancorp Announces Earnings Call on April 23, 2026

Eagle Bancorp, Inc., a Nasdaq-listed community bank holding company based in Bethesda, Maryland, announced its upcoming Q1 2026 earnings call. The company will release its financial results after market close on April 22, 2026, with a teleconference involving the CEO and CFO scheduled the next morning. The event will be accessible via telephone and…

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Ascendis Pharma announced that it will directly list its ordinary shares on Nasdaq starting April 20, 2026, exchanging all existing American Depositary Shares (ADSs) for ordinary shares at a one-for-one ratio. This move aims to simplify the company's listing structure, potentially increase institutional ownership, improve liquidity, and facilitate …

Endeavour Silver Produces 1,875,375 Oz Silver and 11,740 Oz Gold, for a total of 3.3 Million Silver Equivalent Oz in Q1 2026

Endeavour Silver Produces 1,875,375 Oz Silver and 11,740 Oz Gold, for a total of 3.3 Million Silver Equivalent Oz in Q1 2026

Endeavour Silver Corp. announced Q1 2026 production results, delivering 1,875,375 oz of silver, 11,740 oz of gold, and 3.3 million silver equivalent ounces boosted by mine expansions and improved recoveries across key sites including Terronera, Guanaceví, and Kolpa. Despite some weather-related and operational challenges, the company achieved signi…